FCM
HIMS icon

Fieldview Capital Management’s Hims & Hers Health HIMS Stock Holding History

Fieldview Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
6,073
-28,434
-82% -$763K 0.06% 479
2026
Q1 		$716K Buy
+34,507
New +$815K 0.21% 161
2025
Q3 		– Sell
-9,111
Closed -$454K – 454
2025
Q2 		$454K Buy
+9,111
New +$412K 0.07% 258

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fieldview Capital Management's HIMS Position: Q2 2026 in Review

Fieldview Capital Management reduced its Hims & Hers Health (HIMS) stake by 82% in Q2 2026, selling an estimated $763K and leaving 6,073 shares worth $211K. The position accounts for 0.06% of the portfolio, ranked #479.

Fieldview Capital Management first reported a position in HIMS in Q2 2025 and has held it in 3 quarters since. The position peaked at $716K in Q1 2026. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Fieldview Capital Management held 6,073 shares of Hims & Hers Health worth $211K as of Q2 2026.
  • Fieldview Capital Management sold 28,434 Hims & Hers Health shares in Q2 2026, an estimated $763K.
  • Hims & Hers Health made up 0.06% of Fieldview Capital Management's portfolio in Q2 2026, its #479 holding.
  • Fieldview Capital Management first reported a position in Hims & Hers Health in Q2 2025 and has held it in 3 quarters since.
  • Fieldview Capital Management's Hims & Hers Health position peaked at $716K in Q1 2026.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.